Invention Grant
US07973151B2 Nucleic acid encoding modified human thymic stromal lymphopoietin
有权
编码修饰人胸腺基质淋巴细胞生成素的核酸
- Patent Title: Nucleic acid encoding modified human thymic stromal lymphopoietin
- Patent Title (中): 编码修饰人胸腺基质淋巴细胞生成素的核酸
-
Application No.: US12723499Application Date: 2010-03-12
-
Publication No.: US07973151B2Publication Date: 2011-07-05
- Inventor: Stewart D. Lyman , Kirk P. Van Ness , Raymond J. Paxton
- Applicant: Stewart D. Lyman , Kirk P. Van Ness , Raymond J. Paxton
- Applicant Address: US CA Thousand Oaks
- Assignee: Amgen Inc.
- Current Assignee: Amgen Inc.
- Current Assignee Address: US CA Thousand Oaks
- Agent Thomas J. Wrona
- Main IPC: C12N5/10
- IPC: C12N5/10 ; C12N15/19 ; C12N15/63 ; C12N15/64
Abstract:
Modified, furin resistant human TSLP polypeptides and polynucleotides encoding the modified human TSLP polypeptides are provided. Pharmaceutical compositions, B and T cell activation agents, assays and methods of use are also described.
Public/Granted literature
- US20100167393A1 MODIFIED HUMAN THYMIC STROMAL LYMPHOPOIETIN Public/Granted day:2010-07-01
Information query
